NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 20,100
-600 (-2.90%)
Apr 30, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 243.05 billion as of April 30, 2026.
Market Cap
243.05B
Enterprise Value
224.81B
Revenue
2.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,100.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 243.05B, an increase of 4.33%. That is a compound annual growth rate of 5.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 243.05B | -6.13% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 68.19T |
| Celltrion | 42.76T |
| ALTEOGEN | 20.33T |
| Samsung Epis Holdings | 13.91T |
| EASY BIO,Inc. | 261.02B |
| JETEMA, | 260.84B |
| Genexine | 254.69B |
| Interojo | 253.96B |